Category: Earnings Reports

Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business

COVID-19 vaccine. Dado Ruvic/Reuters Novavax shares sank 25% after it said it has “substantial doubt” about its ability to stay in business. The biotech plans spending cuts after it fourth-quarter loss was twice as deep as analysts expected. It said there’s “significant uncertainty” about its revenue, US government funding and unresolved arbitration. Novavax shares sank as much as 25% after the COVID-19 vaccine maker warned…